Browse By

Meet Our Kane Biotech Team

Kane Biotech is THE Biofilm Company with 81 patents and patents pending. Biofilms exhibit a mode of growth that allows survival in a hostile environment, so it is not surprising a considerable number of chronic bacterial infections involve biofilms. New understandings of how biofilms develop

Understanding Biofilms

Biofilms are estimated to be responsible for 80% of all human infections and cost industry, cities and hospitals in excess of $500 billion each year. Biofilms are formed when bacteria and/or fungi adhere to surfaces and excrete a glue-like substance that acts as an anchor

Biofilm Research Leads to Folliculitis Relief

Kane Biotech was formed in 2001, as a discovery and development company focused on novel technologies that prevent and disperse bacterial biofilms. Kane has worked to translate these discoveries into innovative solutions for animal and human conditions impacted by biofilms. 𝟖𝟎% of all human bacterial

Kane Biotech: Personal DermaKB™ Stories Meet Rina Grasman

Kane Biotech was formed in 2001, as a discovery and development company focused on novel technologies that prevent and disperse bacterial biofilms. Kane has worked to translate these discoveries into innovative solutions for animal and human conditions impacted by biofilms. DermaKB™ products are envisioned, tested,